Dark Forest Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
+13,799
New +$1.82M 0.11% 324
2025
Q4
Sell
-8,844
Closed -$982K 1119
2025
Q3
$982K Buy
+8,844
New +$1.01M 0.04% 747
2024
Q4
Sell
-9,079
Closed -$761K 1086
2024
Q3
$761K Buy
9,079
+3,007
+50% +$229K 0.1% 237
2024
Q2
$417K Buy
6,072
+3,302
+119% +$220K 0.08% 320
2024
Q1
$203K Buy
+2,770
New +$213K 0.03% 619
2023
Q4
Sell
-8,354
Closed -$626K 722
2023
Q3
$626K Sell
8,354
-86
-1% -$6.62K 0.05% 617
2023
Q2
$650K Buy
8,440
+6,277
+290% +$501K 0.06% 504
2023
Q1
$179K Buy
+2,163
New +$179K 0.04% 436
2022
Q1
Sell
-47
Closed -$3K 1465
2021
Q4
$3K Sell
47
-433
-90% -$29.8K ﹤0.01% 1261
2021
Q3
$34K Buy
+480
New +$33.7K 0.01% 666

Other funds holding GILD

Dark Forest Capital Management's GILD Position: Q2 2026 in Review

Dark Forest Capital Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 13,799 shares worth $1.74M. The stake represents 0.11% of the portfolio and ranks #324 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in GILD as recently as Q3 2025.

Dark Forest Capital Management first reported a position in GILD in Q3 2021 and has held it in 10 quarters since. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Dark Forest Capital Management held 13,799 shares of Gilead Sciences worth $1.74M as of Q2 2026.
  • Gilead Sciences was a new Dark Forest Capital Management position in Q2 2026.
  • Gilead Sciences made up 0.11% of Dark Forest Capital Management's portfolio in Q2 2026, its #324 holding.
  • Dark Forest Capital Management first reported a position in Gilead Sciences in Q3 2021 and has held it in 10 quarters since.
  • 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.